Sentence examples for prominent classes in from inspiring English sources

In the browse page of BioPhytMol website, prominent classes in BioPhytMol have been shown as a tag-cloud (http://ab-openlab.csir.res.in/biophytmol/browse.php).php

Interestingly, in a global smRNA size distribution analysis we found that the 24-nt smRNAs were the most prominent class in the seed (immature coat and cotyledon) libraries while in the organs from germinating or adult plants (stem, leaf and germinating cotyledon) the 21-nt smRNAs had the largest number of unique reads.

The most prominent classes of sRNAs in diatoms were repeat-associated sRNAs and tRNA-derived sRNAs.

One of the most prominent classes of the defence-related genes in our analysis was represented by protease inhibitors.

Cyanine dyes (CDs) represent one of the most prominent classes of optical contrast agents with ideal properties for in vivo imaging.

ACO was firstly presented by Marco Dorigo in 1992 [30, 31] and is one of the most prominent classes of Swarm intelligence.

As can be seen in Figure 4, anabolic processes such as vitamin production, amino acid and aromatic compound biosynthesis, heterocycle metabolic processes, carbohydrate, lipid and cofactor metabolism are among the most prominent repressed classes in both DTT-treated as well as Hac1-overproducing cells.

Engineered binding proteins derived from non-antibody scaffolds constitute an increasingly prominent class of reagents in both research and therapeutic applications.

In summary, a prominent class of biomolecules that role in many physiological processes of mollusks, including reproduction, is characterized by biogenic monoamines.

Finally, while HDAC1 is the most prominent Class I/II HDAC in RA synovial tissue and FLS [ 1, 6], silencing of either HDAC1 or HDAC2 have similar effects on FLS survival and proliferation [ 6].

The previous $195 million deal, brokered last September through Milberg Weiss Bershad & Schulman, the prominent class-action law firm, collapsed in recent months when nearly one in four eligible investors chose not to take part, saying that it did not offer them enough compensation.